Revitus

Revitus is a rejuvenation biotechnology company dedicated to developing a new class of medicines designed to treat age-related diseases by reversing the aging process at the cellular level. Led by Dr. Michael West, a pioneer in the fields of stem cells and longevity, the company utilizes its proprietary Induced Tissue Regeneration (ITR) platform to reset the epigenetic state of adult cells to a more youthful, regenerative phenotype. This approach aims to restore the body's natural ability to repair and replace damaged tissues, targeting conditions such as heart failure, neurodegeneration, and macular degeneration. Revitus operates at the intersection of developmental biology and regenerative medicine, seeking to extend human healthspan through innovative genetic and cellular interventions.